Women's health

VTE risk with newer hormonal contraceptives
Venous thromboembolism is a recognized adverse event linked to hormonal contraceptives, with an increased risk related to higher estrogen dose and progestin type, in particular depot medroxyprogesterone acetate.
Health Canada approves first pill to treat postpartum depression
Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days.

Can’t take hormone therapy for menopause? What are other options?

Beyond lifestyle changes, some nonhormonal prescription medicines have been shown to ease menopausal symptoms.
There are more than 100 autoimmune diseases, and they mostly strike women. Here’s what to know

New research is raising the prospect of treatments that might do more than tamp down symptoms.
The U.S. FDA removes a long-standing warning from hormone-based menopause drugs

Dr. Steven Fleischman, president of the American College of Obstetricians and Gynecologists, said the warnings have created a lot of hesitancy among patients.
Does breast cancer risk differ based on hormonal contraceptive ingredients?

Study estimates the difference in breast cancer risk associated with different hormonal contraceptive formulations in adolescents and premenopausal women.
Women working the night shift: risk of asthma higher

Association could be the result of disruptions in the circadian rhythm, which could alter the production of sex hormones.
New Canadian consensus guidelines on managing male and female pattern hair loss

A panel of Canadian experts has developed consensus recommendations for the management of androgenetic alopecia in male and female adults.
Thin endometrium may not be a barrier to IVF

Natural cycles may contribute to improved live birth rates.
Canadian menopausal hormone therapy dosage equivalency table now available

This new Canadian Menopause Society resource is designed to simplify menopausal hormone therapy and facilitate product comparisons.

VTE risk with newer hormonal contraceptives

Health Canada approves first pill to treat postpartum depression

Can’t take hormone therapy for menopause? What are other options?

There are more than 100 autoimmune diseases, and they mostly strike women. Here’s what to know

The U.S. FDA removes a long-standing warning from hormone-based menopause drugs

Does breast cancer risk differ based on hormonal contraceptive ingredients?

Women working the night shift: risk of asthma higher

New Canadian consensus guidelines on managing male and female pattern hair loss

Thin endometrium may not be a barrier to IVF

Canadian menopausal hormone therapy dosage equivalency table now available